Keybanc Maintains Overweight on ICU Medical, Raises Price Target to $136
Portfolio Pulse from Benzinga Newsdesk
Keybanc analyst Brett Fishbin has maintained an Overweight rating on ICU Medical (NASDAQ:ICUI) and increased the price target from $134 to $136.
February 28, 2024 | 10:05 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Keybanc analyst Brett Fishbin has reaffirmed an Overweight rating on ICU Medical and raised the price target from $134 to $136.
The increase in price target by Keybanc suggests a positive outlook on ICU Medical's stock, likely due to favorable analysis by the analyst. This could lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100